https://www.selleckchem.com/pr....oducts/asciminib-abl
ytes, and were later recruited to flowering mechanism in angiosperms. The expanding armamentarium of wearable activity monitors (WAMs) offers new opportunities to supplement physician-assessed performance status (PS) with real-life patient activity data. These data could guide clinical decision making or serve as a measure of treatment outcome. However, information on the association between physical activity (PA) and sedentary behavior (S monitored with wearables (i.e., WAM metrics) and PS in patients with cancer is needed.